Senior insider sale
Interim CFO at AVALO THERAPEUTICS, INC. — senior position signals high conviction
$1.26M
79.87K shares
What this filing means
SULLIVAN CHRISTOPHER RYAN plans to sell 79.87K shares of AVALO THERAPEUTICS, INC. valued at approximately $1.26M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/6/2026ACC: 0001950047-26-004142
Officer· Interim CFO
Since Apr 2020
79.87K
Shares to sell
$1.26M
Approx. market value
47K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
5/6/2026
47KTotal acquired47K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/6/2026 | Exercise of Stock Options Cash | 47K | — |
| Total | 47K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
8.46K
Market value
$111.9K
4/30/2026
—Completed
Units to sell
8.46K
Market value
$110.7K
4/29/2026
—Completed
Units to sell
7.98K
Market value
$136.8K
4/2/2026
—Completed
Units to sell
7.98K
Market value
$133.8K
4/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
47K
Market value
$764.2K
5/6/2026
Total
Units
79.87K
Value
$1.26M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/30/2026 | 8.46K | $111.9K | — | Completed |
4/29/2026 | 8.46K | $110.7K | — | Completed |
4/2/2026 | 7.98K | $136.8K | — | Completed |
4/1/2026 | 7.98K | $133.8K | — | Completed |
| Planned — Approximate Date | ||||
5/6/2026 | 47K | $764.2K | NASDAQ | Planned |
| Total | 79.87K | $1.26M | ||